Simões, A E S <br/><br/>
Aberrant MEK5/ERK5 signalling contributes to human colon cancer progression via NF-κB activation.  [electronic resource] 

 -  Cell death & disease  Apr 2015 
 - e1718 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>2041-4889 
<br/><br/><label>Standard No.: </label>10.1038/cddis.2015.83  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Animals<br/>Cell Movement--physiology<br/>Colonic Neoplasms--enzymology<br/>Disease Progression<br/>Female<br/>Humans<br/>MAP Kinase Signaling System<br/>Male<br/>Mice<br/>Middle Aged<br/>Mitogen-Activated Protein Kinase 7--metabolism<br/>NF-kappa B--metabolism<br/>Phosphorylation<br/>Signal Transduction<br/>Xenograft Model Antitumor Assays